Resistance pattern of 2 816 isolates isolated from 17 631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution

Acta Oncologica

Volumn 36, Issue 6, 1997, Pages 643-649

  Trupl, Jan ^a   Kunová, Alena ^a   Oravcová, Eva ^c   Pichňa, Peter ^c   Kukučková, Eva ^b   Grausova, Silvia ^b   Grey, Eva ^a,d   Spanik, Stanislav ^a,d   Demitrovičová, Andrea ^b   Kral'ovičová, Klaudia ^b   Lacka, Jozef ^e   Krupova, Iveta ^c,d   Svec, Juraj ^e   Koren, Pavol ^b   Krčméry Jr , Vladimir ^b,d,f  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b TRNAVA UNIVERSITY   (Slovakia)

^c Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^d St Elisabeth Cancer Institute Bratislava   (Slovakia)

^e Physics and Informatics   (Slovakia)

^f Heydukova 10   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; AMINOGLYCOSIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANCER; CANDIDA GLABRATA; CANDIDA KRUSEI; FUNGEMIA; FUNGUS IDENTIFICATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SLOVAKIA; STENOTROPHOMONAS MALTOPHILIA; BLOOD; CLINICAL TRIAL; DRUG COMBINATION; MICROBIOLOGY; MULTICENTER STUDY; NEOPLASM;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BACTEREMIA; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FLUCONAZOLE; FUNGEMIA; HUMANS; NEOPLASMS; OFLOXACIN;

EID: 9844247988     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001329     Document Type: Article

References (17)

1. Bogacrts M. Antimicrobial prophylaxis in European hematology centers. EORTC Antifungal Cooperative Group Annual Report. Brussels, 1994: 35 pp.
2. Kern W, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Emergence of fluoroquinolone-resistant E. coli at a cancer center. Antimicrob Agents Chemoth 1994; 38: 681 7.
3. Wingard J, Merz GW. Torulopsis glabrata fungemias in a bone marrow transplant unit after prophylactic use of fluconazole. Antimicrob Ag Chemoth 1992; 33: 491.
4. Wingard J, Merz GW, Kays J. Emergence of C. krusei fungemias in patients receiving prophylaxis with fluconazole during bone marrow transplantation. N Engl J Med 1993; 329: 193.
5. Kunova A, Krčméry V Jr. C. glabrata and C. krusei epidemiology in a cancer center: no association with the use of fluconazole. Chemother 1995; 42: 33.
6. Durand-Gasselin B, Leclereq R, Girand P, et al. Evolution of bacterial susceptibility to antibiotics during a six year period in a hematology unit. J Hosp Inf 1995; 29: 19 33.
7. Meunier F, the EORTC Antimicrobial Therapy Cooperative Group. V-penicillin added to pefloxacin to prevent grampositive bacteremia in cancer patients. JAMA 1995; 144: 164 72.
8. Hughes W, the IDSA Working Group. Guidelines for empiric therapy of neutropenic cancer patients with unexplained fever. J Inf Dis 1991; 142: 499 503.
9. Kunová A, Trupl J, Krčméry, V Jr. Vancomycine resistant S. epidermidis bacteremia in cancer patients. Fur J Clin Microbiol Inf Dis 1995; 12: 1618.
10. Krčméry V Jr, Trupl J, Kunová A. First report on vancomycine resistant Streptococcus mitis bacteremia in leukemic patients. J Chemother 1996; 13: 18.
11. Jones R, Kehrberg EN,. Erwin M, Andersed S. Prevalence of important pathogens and antimicrobial activity of piperacillinbactam in medical centers in the US. Diagn Microbiol Inf Dis 1994; 19: 203 15.
12. Waiter K, Rand K, Jenkins S, et al. Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use. Diagn Microbiol Inf Dis 1994; 18: 181 9.
13. Jones R, Hobay D, the North America Study Group. North American comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. Diagn Microbiol Inf Dis 1994; 18: 49 56.
14. Prosser BLT, Beskid G. Multicenter in vitro comparative study of fluoroquinolones against 25 129 gram positive and gram negative clinical isolates. Diagn Microbiol Inf Dis 1995; 21: 33 45.
15. Goodeman J, the Fluconazol Study Group. A multicentric placebo controlled study on fluconazol in prophylaxis of fungal infections in bone marrow transplant recipients. N Engl J Med 1992; 328: 1322.
16. Ellis J, Spence D. Fluconazole in prophylaxis of invasive fungal infections in neutropenic patients. Fur J Clin Microbiol Inf Dis 1993; 10: 189.
17. Carratalla J, Alcaide F, Fernandez SA, Cordobella X. Linares J, Guidol F. Bacteremia due to Viridans Streptococci that are highly resistant to penicillin. Clin Inf Dis 1995; 20: 1169 73.